Shandong Bestcomm Pharmaceutical

Shandong Bestcomm Pharmaceutical is a prominent Chinese integrated pharmaceutical service provider specializing in drug research, development, and manufacturing. Established in 2000 and based in Jinan, the company offers comprehensive CRO and CDMO services, covering the entire drug development lifecycle from pharmaceutical chemistry to clinical trials and industrialization. Bestcomm is a leader in the generic drug sector, particularly in consistency evaluation and the Marketing Authorization Holder (MAH) system, while also advancing its own pipeline of innovative small molecule drugs. The company serves a global clientele, leveraging its extensive R&D infrastructure to deliver high-quality therapeutic solutions across cardiovascular, metabolic, and anti-infective fields. With over 20 years of experience, Bestcomm has established itself as a key player in the Chinese pharmaceutical R&D landscape, supporting numerous successful drug filings and market launches.